Ribomic (TSE:4591) Research & Development : 円764.33 Mil (TTM As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ribomic Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Ribomic's Research & Development for the three months ended in Sep. 2024 was 円0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was 円764.33 Mil.

Ribomic Research & Development Historical Data

The historical data trend for Ribomic's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ribomic Research & Development Chart

Ribomic Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Research & Development

Get a 7-Day Free Trial

673.61

957.61

1,482.13

1,491.24

764.33

Ribomic Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Research & Development	Get a 7-Day Free Trial															240.99	158.29	162.78	202.27	-

Ribomic Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円764.33 Mil.

Ribomic (TSE:4591) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ribomic Research & Development Related Terms

Thank you for viewing the detailed overview of Ribomic's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Ribomic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071

Website

http://www.ribomic.com

Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Ribomic Headlines

No Headlines